Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Nektar Therapeutics (NKTR)

-NasdaqGS
12.37 Up 0.27(2.23%) Dec 2, 4:00PM EST
Prev Close:12.10
Open:12.10
Bid:8.88 x 100
Ask:12.36 x 200
1y Target Est:20.33
Beta:2.16382
Earnings Date:Feb 27 - Mar 3 (Est.)
Day's Range:11.90 - 12.60
52wk Range:10.52 - 19.98
Volume:1,131,702
Avg Vol (3m):1,866,170
Market Cap:1.89B
P/E (ttm):N/A
EPS (ttm):-1.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 2.23%1.89B
GSKUp 0.72%93.89B
ENZNDown 2.76%19.45M
BMYUp 0.29%93.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.07
Quarterly EPS Est (Dec-16) :-0.27
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):1.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback